Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Orca Biosystems, Inc.
Orca Biosystems, Inc.
Eli Lilly and Company
Meryx, Inc.
Qilu Pharmaceutical Co., Ltd.
Plus Therapeutics
Servier
AO GENERIUM
Corcept Therapeutics
Pfizer
Celgene
BBB-Therapeutics B.V.
AVEO Pharmaceuticals, Inc.
Tracon Pharmaceuticals Inc.